Company profile · Biotech & medical
TSH Biopharm Corporation
東生華製藥股份有限公司 · 8432
What it does
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
TSH Biopharm Corporation develops and markets pharmaceuticals and precision medical testing services.[1]
The company focuses on chronic disease treatments in fields such as cardiovascular, gastroenterological, central nervous system, and ophthalmic drugs.[1]
It also provides precision medical testing, including cancer testing and gene analysis.[1]
Monthly revenue
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$169m | +19.2% | -48.1% |
2024-11 to 2026-10, monthly revenue.
Foreign investors
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | +NT$11m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
Facts
| Full English name | TSH Biopharm Corporation Limited |
|---|---|
| Chinese name | 東生華製藥股份有限公司 |
| Stock code | 8432 (TPEx) |
| Industry | Biotech & medical |
| Founded | 01 Sep 2010 |
| Listed | 30 Apr 2012 |
| Paid-in capital | NT$384m |
| Chairman | 林全 |
| President | 楊思源 |
| Headquarters | 3F-1,No.3-1, Park St., Nangang Dist., Taipei,Taiwan, R.O.C. |
| Website | http://www.tshbiopharm.com |
| Official business description | 西藥批發零售業 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Sources
- Annual report 2025 (English), business scope · annual_report · retrieved 04 Nov 2026
Using it at work? Join the team-plan waiting list